| Primary |
| Type 2 Diabetes Mellitus |
28.2% |
| Cardiac Failure Congestive |
8.7% |
| Cardiac Failure |
7.8% |
| Pain |
7.8% |
| Gout |
5.8% |
| Hypertension |
5.8% |
| Constipation |
3.9% |
| Coronary Artery Disease |
3.9% |
| Anxiety |
2.9% |
| Lung Disorder |
2.9% |
| Oedema |
2.9% |
| Polyuria |
2.9% |
| Rheumatoid Arthritis |
2.9% |
| Anaemia |
1.9% |
| Depression |
1.9% |
| Diabetes Mellitus |
1.9% |
| Pancreatitis Chronic |
1.9% |
| Pulmonary Arterial Hypertension |
1.9% |
| Pulmonary Embolism |
1.9% |
| Rhinitis |
1.9% |
|
| Bronchitis |
12.1% |
| Hypokalaemia |
9.1% |
| Hyponatraemia |
9.1% |
| Dehydration |
6.1% |
| Renal Failure Acute |
6.1% |
| Syncope |
6.1% |
| Upper Limb Fracture |
6.1% |
| Weight Decreased |
6.1% |
| Weight Increased |
6.1% |
| Body Height Abnormal |
3.0% |
| Confusional State |
3.0% |
| Dyspnoea |
3.0% |
| Fatigue |
3.0% |
| Joint Swelling |
3.0% |
| Malaise |
3.0% |
| Pancreatitis Chronic |
3.0% |
| Pulmonary Arterial Hypertension |
3.0% |
| Renal Failure |
3.0% |
| Renal Failure Chronic |
3.0% |
| Restless Legs Syndrome |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
30.1% |
| Cardiac Failure Congestive |
14.8% |
| Cardiac Failure |
5.6% |
| Hypertension |
5.1% |
| Neuralgia |
4.6% |
| Diabetes Mellitus |
4.1% |
| Asthma |
3.6% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Neuropathy Peripheral |
3.1% |
| Pain |
3.1% |
| Pulmonary Embolism |
3.1% |
| Back Pain |
2.6% |
| Cardiovascular Disorder |
2.6% |
| Constipation |
2.6% |
| Gout |
2.6% |
| Pulmonary Arterial Hypertension |
2.6% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Polyuria |
2.0% |
| Amyloidosis |
1.5% |
| Anxiety |
1.5% |
|
| Road Traffic Accident |
14.9% |
| Renal Failure Acute |
12.8% |
| Renal Failure |
8.5% |
| Weight Decreased |
8.5% |
| Drug Hypersensitivity |
6.4% |
| Hypokalaemia |
6.4% |
| Shock |
6.4% |
| Hypotension |
4.3% |
| Pulmonary Arterial Hypertension |
4.3% |
| Vomiting |
4.3% |
| Wrong Drug Administered |
4.3% |
| Dysuria |
2.1% |
| Electrocardiogram Qt Prolonged |
2.1% |
| Gait Disturbance |
2.1% |
| Hallucination |
2.1% |
| Hepatic Enzyme Increased |
2.1% |
| Hyperthermia |
2.1% |
| Hyponatraemia |
2.1% |
| Joint Swelling |
2.1% |
| Overdose |
2.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.6% |
| Drug Use For Unknown Indication |
19.1% |
| Hypertension |
6.0% |
| Pain |
5.6% |
| Pulmonary Arterial Hypertension |
2.9% |
| Nuclear Magnetic Resonance Imaging |
2.9% |
| Cardiac Disorder |
2.8% |
| Diabetes Mellitus |
2.7% |
| Cardiac Failure Congestive |
2.4% |
| Atrial Fibrillation |
2.1% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Angiogram |
1.9% |
| Pulmonary Hypertension |
1.6% |
| Coronary Artery Bypass |
1.5% |
| Blood Cholesterol Increased |
1.4% |
| Cardiac Failure |
1.4% |
| Gout |
1.4% |
| Asthma |
1.4% |
| Oedema |
1.3% |
| Blood Pressure |
1.2% |
|
| Weight Increased |
15.0% |
| Vomiting |
12.4% |
| Weight Decreased |
10.0% |
| Renal Failure |
6.4% |
| Renal Failure Acute |
5.2% |
| Pain |
4.6% |
| Wound Infection |
4.4% |
| Death |
4.2% |
| Wheezing |
4.2% |
| Anhedonia |
3.6% |
| Syncope |
3.6% |
| Cardiac Failure Congestive |
3.4% |
| Dyspnoea |
3.4% |
| Injury |
3.2% |
| Unevaluable Event |
3.0% |
| Respiratory Failure |
2.8% |
| Urinary Tract Infection |
2.8% |
| Oedema Peripheral |
2.6% |
| Type 2 Diabetes Mellitus |
2.6% |
| Nausea |
2.4% |
|
| Interacting |
| Neuralgia |
28.8% |
| Gastrooesophageal Reflux Disease |
13.5% |
| Constipation |
9.6% |
| Joint Swelling |
9.6% |
| Sinus Tachycardia |
9.6% |
| Product Used For Unknown Indication |
7.7% |
| Obstruction |
5.8% |
| Oedema |
5.8% |
| Pain |
3.8% |
| Chordoma |
1.9% |
| Hypokalaemia |
1.9% |
| Ill-defined Disorder |
1.9% |
|
| Hypokalaemia |
62.5% |
| Volume Blood Decreased |
25.0% |
| Hepatic Enzyme Increased |
12.5% |
|
